Noona Ambartsumian

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Anti-S100A4 Antibody Therapy Is Efficient in Treating Aggressive Prostate Cancer and Reversing Immunosuppression: Serum and Biopsy S100A4 as a Clinical Predictor.

Anti-S100A4 Antibody Therapy Is Efficient in Treating Aggressive Prostate Cancer and Reversing Immunosuppression: Serum and Biopsy S100A4 as a Clinical Predictor.

Journal: Molecular cancer therapeutics

Published: May 15, 2020

Neutralization of S100A4 induces stabilization of atherosclerotic plaques: role of smooth muscle cells.

Neutralization of S100A4 induces stabilization of atherosclerotic plaques: role of smooth muscle cells.

Journal: Cardiovascular research

Published: March 31, 2020

The Multifaceted S100A4 Protein in Cancer and Inflammation.

The Multifaceted S100A4 Protein in Cancer and Inflammation.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: February 03, 2019

Laminin α1 orchestrates VEGFA functions in the ecosystem of colorectal carcinoma.

Laminin α1 orchestrates VEGFA functions in the ecosystem of colorectal carcinoma.

Journal: Biology of the cell

Published: January 17, 2018

The role of S100a4 (Mts1) in Apc- and Smad4-driven tumour onset and progression.

The role of S100a4 (Mts1) in Apc- and Smad4-driven tumour onset and progression.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 30, 2016

S100A4, a link between metastasis and inflammation

S100A4, a link between metastasis and inflammation

Journal: Molekuliarnaia biologiia

Published: February 01, 2016

Spatial organization of the tenascin-C microenvironment in experimental and human cancer.

Spatial organization of the tenascin-C microenvironment in experimental and human cancer.

Journal: Cell adhesion & migration

Published: January 23, 2015

S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance.

S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance.

Journal: BMC cancer

Published: October 10, 2014

Screening and identification of small molecule inhibitors of ErbB2-induced invasion.

Screening and identification of small molecule inhibitors of ErbB2-induced invasion.

Journal: Molecular oncology

Published: February 18, 2014

A generally applicable translational strategy identifies S100A4 as a candidate gene in allergy.

A generally applicable translational strategy identifies S100A4 as a candidate gene in allergy.

Journal: Science translational medicine

Published: January 10, 2014

A link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4.

A link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4.

Journal: Oncogene

Published: July 03, 2013

The S100A4 Oncoprotein Promotes Prostate Tumorigenesis in a Transgenic Mouse Model: Regulating NFκB through the RAGE Receptor.

The S100A4 Oncoprotein Promotes Prostate Tumorigenesis in a Transgenic Mouse Model: Regulating NFκB through the RAGE Receptor.

Journal: Genes & cancer

Published: April 03, 2013

Showing 1-12 of 16

Last Updated: 09/26/2026